Skip to main content
Equibles

Gary Jay Nachman

Analyst

Conochord Genuity

Equibles does not estimate personal net worth.

About Gary Jay Nachman

Gary Jay Nachman is recorded as Analyst at Conochord Genuity. Gary Jay Nachman has spoken on 1 earnings call across 1 company, most recently for AbbVie Inc. on April 29, 2026. The companies whose calls Gary Jay Nachman spoke on are classified in the Healthcare sector.

Gary Jay Nachman on recent calls

“So, first for the additional indications for Renvogue. As they start to come through, vitiligo and alopecia areata will be next. Are you still thinking all those indications can be $2 billion in aggregate?”
Analyst — Conochord Genuity, AbbVie Inc. Q1 FY2026 Earnings Call ·

Affiliation history

  • Conochord Genuity

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity